html { overflow: visible; height: auto; } .MainNav_ItemWrapper:hover .Subnavigation_Wrapper, .MainNav_Item:focus + .Subnavigation_Wrapper { display: block; } .Header-FixedHeight .Dialoog, .Header-FixedHeight .Title_Wrapper, .Accordion_ContentContainer.Hidden { height: auto !important; visibility: visible; } .Dialoog_Step.Invisible, .Title_Wrapper.Invisible, main.Invisible, .js-GridItem { transform: none; opacity: 1; } .Dialoog_Form, .js-OptionsOpenBtn, .Image_Wrapper-Scaled, .Video_Wrapper-Scaled, img[data-src] { display: none; } .js-MasonryGrid { display: flex; flex-wrap: wrap; }

go to main content

- Pagina niet beschikbaar in Nederlands ( NL )
- Seite nicht verfügbar auf Deutsch ( DE )

Go to Radboudumc Radboudumc

Research group Hereditary cancer

Welcome to Research

I am looking for ...

information on how Radboudumc conducts research →
opportunities for my career within Radboudumc research →
opportunities to participate or invest in Radboudumc research →

Research Hereditary cancer

About

We conduct research on the genetic factors that lead to hereditary cancer predisposition. We search for the cancer risks, effectiveness of prevention and treatment of PTEN hamartoma Tumour syndrome (PHTS). We perform research to optimize current strategies diagnosing hereditary cancer.

Research group leader

prof. dr. Nicoline Hoogerbrugge

Publications

See some of our most important scientific articles.

Listen

Publications

See the publication list on Web of Science.

Employees
mijnRadboud

This website uses cookies. Read more about cookies.